D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 88 Citations 19,557 473 World Ranking 8552 National Ranking 40

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Schizophrenia
  • Psychiatry

W. Wolfgang Fleischhacker mainly focuses on Psychiatry, Schizophrenia, Internal medicine, Antipsychotic and Psychosis. His studies in Psychiatry integrate themes in fields like Adverse effect, Randomized controlled trial and Clinical psychology. He has included themes like Psychosocial, Quality of life, Pediatrics and Compliance in his Schizophrenia study.

The concepts of his Internal medicine study are interwoven with issues in Anesthesia, Endocrinology, Clozapine and Atypical antipsychotic. The Antipsychotic study combines topics in areas such as Clinical trial, Health care and Cohort study. W. Wolfgang Fleischhacker has included themes like Sexual intercourse, Significant difference and Risk factor in his Psychosis study.

His most cited work include:

  • Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. (360 citations)
  • Guidelines for depot antipsychotic treatment in schizophrenia (287 citations)
  • Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. (276 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Psychiatry, Schizophrenia, Internal medicine, Antipsychotic and Clozapine. His Psychiatry research is multidisciplinary, incorporating perspectives in Clinical trial and Clinical psychology. He interconnects Bipolar disorder and Cognition in the investigation of issues within Clinical psychology.

His research integrates issues of Psychosocial, Psychosis and Psychopathology in his study of Schizophrenia. His studies deal with areas such as Gastroenterology, Placebo, Endocrinology and Atypical antipsychotic as well as Internal medicine. His studies in Antipsychotic integrate themes in fields like Adverse effect and Olanzapine.

He most often published in these fields:

  • Psychiatry (46.30%)
  • Schizophrenia (30.43%)
  • Internal medicine (24.13%)

What were the highlights of his more recent work (between 2012-2021)?

  • Psychiatry (46.30%)
  • Schizophrenia (30.43%)
  • Antipsychotic (18.04%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Psychiatry, Schizophrenia, Antipsychotic, Internal medicine and Clinical psychology. W. Wolfgang Fleischhacker has researched Psychiatry in several fields, including Placebo and Clinical trial. His Schizophrenia research integrates issues from Psychosocial, Psychosis, Pediatrics and Double blind.

Within one scientific family, he focuses on topics pertaining to Olanzapine under Antipsychotic, and may sometimes address concerns connected to Quetiapine, Schizoaffective disorder, Risperidone and Clozapine. His Internal medicine study combines topics from a wide range of disciplines, such as Paliperidone Palmitate, Akathisia and Positive and Negative Syndrome Scale. His Clinical psychology research includes elements of Psychological intervention, Bipolar disorder and Mental illness.

Between 2012 and 2021, his most popular works were:

  • Stratified medicine for mental disorders (130 citations)
  • Critical review of antipsychotic polypharmacy in the treatment of schizophrenia. (108 citations)
  • Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study (94 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Schizophrenia
  • Psychiatry

His primary areas of study are Psychiatry, Schizophrenia, Antipsychotic, Clinical psychology and Randomized controlled trial. His Psychiatry study combines topics in areas such as Clinical trial and Pediatrics. His Schizophrenia research is multidisciplinary, relying on both Discontinuation, Young adult, Bipolar disorder, Depression and Cognition.

W. Wolfgang Fleischhacker combines subjects such as Internal medicine, Psychosis and Clozapine with his study of Antipsychotic. His Psychosis study integrates concerns from other disciplines, such as Neuropsychology and Intensive care medicine. His study in Clinical psychology is interdisciplinary in nature, drawing from both Psychosocial, Facial expression and Positive and Negative Syndrome Scale.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

S. Miyamoto;N. Miyake;Lars Jarskog;W. W. Fleischhacker.
Molecular Psychiatry (2012)

624 Citations

Guidelines for depot antipsychotic treatment in schizophrenia

John M.John Kane;Eugenio Aguglia;A. CarloA. Altamura;José Luis Ayuso Gutierrez.
European Neuropsychopharmacology (1998)

432 Citations

Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges.

W Wolfgang Fleischhacker;Marcelo Cetkovich-Bakmas;Marc De Hert;Charles H Hennekens.
The Journal of Clinical Psychiatry (2008)

427 Citations

Comparison of acamprosate and placebo in long-term treatment of alcohol dependence.

A.B Whitworth;H Oberbauer;W.W Fleischhacker;O.M Lesch.
The Lancet (1996)

426 Citations

Sex differences in cognitive functions

Elisabeth M. Weiss;Georg Kemmler;Eberhard A. Deisenhammer;W.Wolfgang Fleischhacker.
Personality and Individual Differences (2003)

423 Citations

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic.

W Wolfgang Fleischhacker;Mariëlle Eerdekens;Keith Karcher;Gary Remington.
The Journal of Clinical Psychiatry (2003)

400 Citations

Metabolic side effects of antipsychotic medication.

A. Tschoner;J. Engl;M. Laimer;S. Kaser.
International Journal of Clinical Practice (2007)

373 Citations

Quality of life in breast cancer patients--not enough attention for long-term survivors?

Bernhard Holzner;Georg Kemmler;Martin Kopp;Roland Moschen.
Psychosomatics (2001)

351 Citations

Compliance with antipsychotic drug treatment: influence of side effects

Fleischhacker Ww;Meise U;Günther;Kurz M.
Acta Psychiatrica Scandinavica (1994)

312 Citations

Sex differences in brain activation pattern during a visuospatial cognitive task: a functional magnetic resonance imaging study in healthy volunteers.

E. Weiss;C.M. Siedentopf;A. Hofer;E.A. Deisenhammer.
Neuroscience Letters (2003)

260 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing W. Wolfgang Fleischhacker

Christoph U. Correll

Christoph U. Correll

Charité - University Medicine Berlin

Publications: 96

Gary Remington

Gary Remington

Centre for Addiction and Mental Health

Publications: 80

Stefan Leucht

Stefan Leucht

Technical University of Munich

Publications: 65

Hans-Jürgen Möller

Hans-Jürgen Möller

Ludwig-Maximilians-Universität München

Publications: 61

John M. Kane

John M. Kane

Zucker Hillside Hospital

Publications: 59

Eduard Vieta

Eduard Vieta

University of Barcelona

Publications: 51

Jeffrey A. Lieberman

Jeffrey A. Lieberman

Columbia University

Publications: 47

Marc De Hert

Marc De Hert

KU Leuven

Publications: 45

René S. Kahn

René S. Kahn

Icahn School of Medicine at Mount Sinai

Publications: 42

Herbert Y. Meltzer

Herbert Y. Meltzer

Northwestern University

Publications: 40

Pierre-Michel Llorca

Pierre-Michel Llorca

University of Clermont Auvergne

Publications: 40

Peter Falkai

Peter Falkai

Ludwig-Maximilians-Universität München

Publications: 39

James L. Kennedy

James L. Kennedy

Centre for Addiction and Mental Health

Publications: 39

Siegfried Kasper

Siegfried Kasper

Medical University of Vienna

Publications: 38

Silvana Galderisi

Silvana Galderisi

University of Campania "Luigi Vanvitelli"

Publications: 34

Anthony S. David

Anthony S. David

University College London

Publications: 33

Trending Scientists

Alexei G. Myasnikov

Alexei G. Myasnikov

Stevens Institute of Technology

Steven Gao

Steven Gao

University of Kent

Xinping Yan

Xinping Yan

Wuhan University of Technology

Joost N. H. Reek

Joost N. H. Reek

University of Amsterdam

Jiming Bao

Jiming Bao

University of Houston

Michiel van Breugel

Michiel van Breugel

Smithsonian Tropical Research Institute

John J. Burke

John J. Burke

Agricultural Research Service

Yasuhito Yuasa

Yasuhito Yuasa

Tokyo Medical and Dental University

John S. Gunn

John S. Gunn

Nationwide Children's Hospital

Richard J. Reed

Richard J. Reed

University of Washington

Thomas A. Stoffregen

Thomas A. Stoffregen

University of Minnesota

Jennifer Y. F. Lau

Jennifer Y. F. Lau

Queen Mary University of London

Kathleen A. Welsh-Bohmer

Kathleen A. Welsh-Bohmer

Duke University

Masataka Fukugita

Masataka Fukugita

University of Tokyo

Susan G. Neff

Susan G. Neff

Goddard Space Flight Center

Something went wrong. Please try again later.